ArticleJournal for immunotherapy of cancer2024

Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors.

Juan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.